Viewing Study NCT01585805


Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-02-24 @ 3:13 PM
Study NCT ID: NCT01585805
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-11
First Post: 2012-04-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Pancreatic Adenocarcinoma View
None Metastatic Pancreatic Adenocarcinoma View
None Stage III Pancreatic Cancer AJCC v8 View
None Stage IV Pancreatic Cancer AJCC v8 View
Keywords: